Literature DB >> 16887884

In vivo induction of glial cell proliferation and axonal outgrowth and myelination by brain-derived neurotrophic factor.

Dorien M de Groot1, Anton J M Coenen, Albert Verhofstad, François van Herp, Gerard J M Martens.   

Abstract

Brain-derived neurotrophic factor (BDNF) belongs to the neurotrophin family of neuronal cell survival and differentiation factors but is thought to be involved in neuronal cell proliferation and myelination as well. To explore the role of BDNF in vivo, we employed the intermediate pituitary melanotrope cells of the amphibian Xenopus laevis as a model system. These cells mediate background adaptation of the animal by producing high levels of the prohormone proopiomelanocortin (POMC) when the animal is black adapted. We used stable X. transgenesis in combination with the POMC gene promoter to generate transgenic frogs overexpressing BDNF specifically and physiologically inducible in the melanotrope cells. Intriguingly, an approximately 25-fold overexpression of BDNF resulted in hyperplastic glial cells and myelinated axons infiltrating the pituitary, whereby the transgenic melanotrope cells became located dispersed among the induced tissue. The infiltrating glial cells and axons originated from both peripheral and central nervous system sources. The formation of the phenotype started around tadpole stage 50 and was induced by placing white-adapted transgenics on a black background, i.e. after activation of transgene expression. The severity of the phenotype depended on the level of transgene expression, because the intermediate pituitaries from transgenic animals raised on a white background or from transgenics with only an approximately 5-fold BDNF overexpression were essentially not affected. In conclusion, we show in a physiological context that, besides its classical role as neuronal cell survival and differentiation factor, in vivo BDNF can also induce glial cell proliferation as well as axonal outgrowth and myelination.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887884     DOI: 10.1210/me.2006-0168

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

Review 1.  The Physiology of BDNF and Its Relationship with ADHD.

Authors:  De-Yi Liu; Xue-Mei Shen; Fang-Fen Yuan; Ou-Yang Guo; Yan Zhong; Jian-Guo Chen; Ling-Qiang Zhu; Jing Wu
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

2.  BDNF mRNA expression is significantly upregulated in vestibular schwannomas and correlates with proliferative activity.

Authors:  Frauke Kramer; Timo Stöver; Athanasia Warnecke; Marc Diensthuber; Thomas Lenarz; Kirsten Wissel
Journal:  J Neurooncol       Date:  2009-11-25       Impact factor: 4.130

3.  Oxidative phosphorylated neurofilament protein M protects spinal cord against ischemia/reperfusion injury.

Authors:  Haitao Wang; Su Pan; Xiaoyu Yang; Benqing Zhu; Dalin Wang
Journal:  Neural Regen Res       Date:  2014-09-15       Impact factor: 5.135

4.  Electroacupuncture promotes the proliferation of endogenous neural stem cells and oligodendrocytes in the injured spinal cord of adult rats.

Authors:  Haiying Wu; Min Hu; Dekai Yuan; Haiying Wu; Yunhui Wang; Jing Wang; Tao Li; Chuanyun Qian; Hualin Yu
Journal:  Neural Regen Res       Date:  2012-05-25       Impact factor: 5.135

Review 5.  Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Alejandro F De Nicola; María Meyer; Laura Garay; Maria Sol Kruse; Michael Schumacher; Rachida Guennoun; Maria Claudia Gonzalez Deniselle
Journal:  Cell Mol Neurobiol       Date:  2021-06-17       Impact factor: 5.046

6.  Rat bone marrow-derived Schwann-like cells differentiated by the optimal inducers combination on microfluidic chip and their functional performance.

Authors:  Xiliang Tian; Shouyu Wang; Zhen Zhang; Decheng Lv
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

7.  Traumatic brain injury: future assessment tools and treatment prospects.

Authors:  Steven R Flanagan; Joshua B Cantor; Teresa A Ashman
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.